Celldex Therapeutics reported $1.54B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.




Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Celldex Therapeutics USD 1.35B 146M Jun/2025
Glaxosmithkline GBP 82.21B 2.63B Sep/2025
Pfizer USD 137.53B 6.19B Jun/2025